Systemic disease after hip replacement: Aeromedical implications of arthroprosthetic cobaltism

Aviation Space and Environmental Medicine

Volumn 84, Issue 3, 2013, Pages 242-245

  Sotos, John G ^a   Tower, Stephen S ^b  

^a California National Guard ^*  (United States)

^b Anchorage Fracture and Orthopedic Clinic   (United States)

Author keywords

Blindness; Cardiomyopathy; Chromium; Cobalt; Deafness; Dementia; Depression; Hip prosthesis; Mania; Metal on metal hip; Tinnitus

Indexed keywords

COBALT;

AEROSPACE MEDICINE; ARTICLE; BLOOD; CASE REPORT; COGNITIVE DEFECT; HIP ARTHROPLASTY; HIP OSTEOARTHRITIS; HUMAN; MALE; METAL ON METAL JOINT PROSTHESIS; MIDDLE AGED; SENSORY DYSFUNCTION;

AEROSPACE MEDICINE; ARTHROPLASTY, REPLACEMENT, HIP; COBALT; COGNITION DISORDERS; HUMANS; MALE; METAL-ON-METAL JOINT PROSTHESES; MIDDLE AGED; OSTEOARTHRITIS, HIP; SENSATION DISORDERS;

EID: 84875792407     PISSN: 00956562     EISSN: None     Source Type: Journal    
DOI: 10.3357/ASEM.3262.2013     Document Type: Article

References (16)

1. Bozic KJ, Kurtz S, Lau E, Ong K, Chiu V, et al. The epidemiology of bearing surface usage in total hip arthroplasty in the United States. J Bone Joint Surg Am 2009 ; 91: 1614-20.
2. Burton P. ( 2011 ). Online Case Report. JBJS Blog. Retrieved August 1, 2011, from http:/commentary.jbjs.org/index.php/ 2010/10/203/.
3. Catalani, S, Rizzetti MC, Padovani A, Apostoli P. Neurotoxicity of cobalt. Hum Exp Toxicol 2012 ; 31: 421-37.
4. Cuckler JM. The rationale for metal-on-metal total hip arthroplasty. Clin Orthop Relat Res 2005 ; 441: 132-6.
5. Dahlstrand H, Stark A, Anissian L, Hailer NP. Elevated serum concentrations of cobalt, chromium, nickel, and manganese after metal-on-metal alloarthroplasty of the hip: a prospective randomized study. J Arthroplasty 2009 ; 24: 837-45.
6. Goldhagen M, Fox K. Retained orthopedic hardware and joint replacement (December 2007). In: United States Air Force School of Aerospace Medicine. Waiver guide. Retrieved 2011- 09-18 from: https://kx.afms.mil/kxweb/dotmil/file/web/ctb_071049.pdf.
7. Hart AJ, Sabah S, Henckel J, Lewis A, Cobb J, et al. The painful metal-on-metal hip resurfacing. J Bone Joint Surg Br 2009 ; 91: 738-44.
8. Jacobs JJ, Skipor AK, Campbell PA, Hallab NJ, Urban RM, Amstutaz HC. Can metal levels be used to monitor metal-onmetal hip arthroplasties. J Arthroplasty 2004 ; 19 ( 8, Suppl. 3 ): 59-65.
9. Langton DJ, Jameson SS, Joyce TJ, Gandhi JN, Sidaginamale R, et al. Accelerating failure rate of the ASR total hip replacement. J Bone Joint Surg Br 2011 ; 93: 1011-6.
10. Mao X, Wong AA, Crawford RW. Cobalt toxicity - an emerging clinical problem in patients with metal-on-metal hip prostheses. Med J Aust 2011 ; 194: 649-51.
11. McLeod MN, Gaynes BN, Golden RN. Chromium potentiation of antidepressant pharmacotherapy for dysthymic disorder in 5 patients. J Clin Psychiatry 1999 ; 60: 237-40.
12. Medicines and Healthcare Products Regulatory Agency, United Kingdom. Medical device alert: all metal-on-metal (MoM) hip replacements (MDA/2010/033); 2010. Retrieved August 1, 2011, from: http://www.mhra.gov.uk/Publications/Safetywarnings/ MedicalDeviceAlerts/CON079157.
13. Smith IC, Carson BL. Cobalt: an appraisal of environmental exposure. Ann Arbor, MI: Ann Arbor Science ; 1981.
14. Tower S. Arthroprosthetic cobaltism: identification of the at-risk patient. Alaska Med 2010 ; 52: 28-32.
15. Tower SS. Arthroprosthetic cobaltism: neurological and cardiac manifestations in two patients with metal-on-metal arthroplasty: a case report. J Bone Joint Surg Am 2010 ; 92: 2847-51.
16. U.S. Federal Aviation Administration. 2012 guide for medical examiners. October 1, 2012. Accessed October 21, 2012, from: http://www.faa.gov/about/office_org/headquarters_ offices/avs/offices/aam/ame/guide/.